Home
Knowledge Hub

Knowledge Hub

Featured content

Noble Hosts Ceremony Celebrating Support for Redemption Home

How Pharma Teams Should Approach Autoinjector Device Selection and Design Strategy

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

01

Noble Hosts Ceremony Celebrating Support for Redemption Home

Noble Hosts Ceremony Celebrating Support for Redemption Home

At Noble, creating a positive impact extends beyond the healthcare solutions we provide. It also means supporting the communities where we live and work. Recently, Noble welcomed employees, community leaders, and representatives from Redemption Home to its Orlando headquarters for a special ceremony celebrating the organization’s mission of providing mentorship, stability, and opportunity for young men across Central Florida.

How Pharma Teams Should Approach Autoinjector Device Selection and Design Strategy

How Pharma Teams Should Approach Autoinjector Device Selection and Design Strategy

Learn how pharma teams should approach autoinjector device selection and autoinjector design strategy using patient-first insights, human factors, and real-world use to reduce risk and improve adherence.

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

GLP-1 therapies continue to transform the treatment landscape for obesity and type 2 diabetes. As innovation accelerates, so too does the evolution of how these therapies are delivered.

From Prescription to Persistence: How “Inside-Out” Patient Engagement Is Reshaping Specialty Pharma

From Prescription to Persistence: How “Inside-Out” Patient Engagement Is Reshaping Specialty Pharma

Discover how emerging “inside-out” patient engagement models are transforming specialty pharma by reducing drop-off, improving speed to therapy, and enabling proactive, data-driven support.

Sustainability in Drug Delivery Is a Human Factors Challenge

Sustainability in Drug Delivery Is a Human Factors Challenge

As sustainability goals reshape the pharmaceutical industry, much of the conversation has focused on materials, propellants, and emissions. In respiratory drug delivery, the transition to low global warming potential (low-GWP) propellants is a prime example of this shift, with the potential to significantly reduce the environmental impact of pressurized metered-dose inhalers (pMDIs).

Noble’s Sean Glynn Discusses First-Dose Confidence and Adherence in Pharmaceutical Executive Podcast

Noble’s Sean Glynn Discusses First-Dose Confidence and Adherence in Pharmaceutical Executive Podcast

Noble’s Director of Patient Engagement Services, Sean Glynn, recently appeared on a Pharmaceutical Executive podcast to discuss the role of first-dose experiences in patient adherence and persistence for self-injectable therapies.